There are many aspects of DOCK4’s role within bone metastasis of breast cancer, which remain to be elucidated, including the possible role of DOCK4 within nonbone metastasis, as well as the interaction of DOCK4 with bisphosphonate treatment and its potential role as an informative biomarker for patient treatment decisions. Here, DOCK4 is linked to breast carcinoma.